MedPath

Effect of intravenous versus perineural dexamethasone on random blood sugar in patients receiving brachial plexus block

Phase 2
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/09/057703
Lead Sponsor
Sri Guru Ram Das Institute of Medical sciences and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients in class ASA I and II

2.Surgery planned under supraclavicular block

3.Non-Diabetic Patients

Exclusion Criteria

1. Patient refusal

2. Infection at the site of injection

3. Contraindications to brachial plexus block

4. Hypersensitivity to any drug used in study

5. Pregnancy

6. Patient on anticoagulants

7. Patient on chronic/acute steroid therapy

8. Perioperative dextrose infusions

9. HbA1c >5.5

10. Weight of the patient <40kgs and >100kgs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in blood sugar levels at baseline & after four hours of administration of <br/ ><br>dexamethasone by the perineural and intravenous routeTimepoint: Before performing supraclavicular brachial plexus block then at 4hrs.
Secondary Outcome Measures
NameTimeMethod
Blood sugar levels at 2,4,8 & 24 hours after dexamethasone administration. <br/ ><br>Duration of analgesia of the three groups <br/ ><br>Requirement of rescue analgesia in the three groupsTimepoint: Before performing supraclavicular brachial plexus block then at 2,4,8 & 24 hours
© Copyright 2025. All Rights Reserved by MedPath